Bed entrapment guidance
This article was originally published in The Gray Sheet
Executive Summary
Final guidance designed to improve the safety of hospital beds issued March 9. The document, "Hospital Bed System Dimensional & Assessment Guidance to Reduce Entrapment," outlines potential entrapment areas and provides design recommendations for manufacturers of new hospital beds, plus suggestions for minimizing the risk of entrapment with existing beds. During the 21 years from 1985 to 2006, the agency received reports of approximately 691 entrapments, including 413 deaths...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.